N-Desmethyl imatinib mesylate

Catalog No.: A70480
Drug Metabolite
N-Desmethyl imatinib mesylate is an active metabolite of imatinib, primarily functioning as a selective inhibitor of the c-Abl kinase. It effectively binds to the c-Abl catalytic domain, obstructing substrate phosphorylation and inhibiting the c-Abl-mediated activation of α-synuclein, as well as associated inflammatory signaling pathways. This compound promotes apoptosis in K562 human leukemia cells and demonstrates enhanced plasma concentrations in gastrointestinal stromal tumor contexts, especially following mild SARS-CoV-2 infection. N-Desmethyl imatinib mesylate is valuable for research into Parkinson's disease, gastrointestinal stromal tumors, and chronic myeloid leukemia.
Grouped product items
Size Price Stock Qty
25mg
$1,275.00
In stock
Bulk Size
Bulk Discount
Free Delivery on orders over $500
Research use only. We do not sell to patients.

Loading distributor info...

Adooq Products cited in reputable paper
Science VOLUME 380, ISSUE 6663 (2023)
Science VOLUME 369, ISSUE 6510 (2020)
Science VOLUME 356, ISSUE 6336 (2017)
Cell Vol. 185 Issue 23 p4428-4447.e28
Cell Vol 177, Issue 7, p1933-1947.e25
Cell Vol 156, Issue 5, p857-1114
Nature Volume 622 Issue 7982 (2023)
Nature volume 620, pages890-897 (2023)
Nature volume 610, pages540-546 (2022)
Nature volume 588, pages83-88 (2020)
Nature volume 574, pages268-272 (2019)
Nature volume 573, pages539-545 (2019)
Nature volume 567, pages118-122 (2019)
Nature volume 551, pages639-643 (2017)
Nature volume 551, pages247-250 (2017)
Nature volume 548, pages356-360 (2017)
Nature volume 545, pages187-192 (2017)
Biological Activity
DescriptionN-Desmethyl imatinib mesylate is an active metabolite of imatinib, primarily functioning as a selective inhibitor of the c-Abl kinase. It effectively binds to the c-Abl catalytic domain, obstructing substrate phosphorylation and inhibiting the c-Abl-mediated activation of α-synuclein, as well as associated inflammatory signaling pathways. This compound promotes apoptosis in K562 human leukemia cells and demonstrates enhanced plasma concentrations in gastrointestinal stromal tumor contexts, especially following mild SARS-CoV-2 infection. N-Desmethyl imatinib mesylate is valuable for research into Parkinson's disease, gastrointestinal stromal tumors, and chronic myeloid leukemia.
Product Information
Catalog NumA70480
FormulaC29H33N7O4S
Molecular Weight575.68
CAS Number404844-03-7
SMILESCS(=O)(O)=O.O=C(NC1=CC=C(C)C(NC2=NC(C3=CC=CN=C3)=CC=N2)=C1)C4=CC=C(CN5CCNCC5)C=C4
SynonymsNorimatinib mesylate; Imatinib metabolite N-Desmethyl imatinib mesylate; CGP 74588 mesylate
Useful Calculator

This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass

    Concentration

    Volume

    Molecular Weight

Please check COA/MSDS for correct molecular weight.

Calculate the dilution required to prepare a stock solution.
This equation is commonly abbreviated as: C1V1 = C2V2

  • C1

    V1

    C2

    V2